Suzie Trigg, Kayla Cristales and Steve Armstrong in Law360: Considering the Current and Future Legality Of CBD


Candies, beverages, lotions, capsules, tinctures and other products that tout the inclusion and benefits of cannabidiol — better known as CBD — seem to be everywhere from your local dog grooming salon, to your favorite clothing retailer, to your chiropractor’s office. How can these products be increasingly available, when the U.S. Food and Drug Administration continues to insist most of them violate the federal Food, Drug & Cosmetic Act?

Some members of Congress and state attorneys general continue to ask similar questions. The maker of the first FDA approved drug with CBD (Epidiolex) on the other hand, has also raised serious concerns that “[i]n opening the door for consumer-market CBD products, FDA risks further diminishing the likelihood that more cannabis-derived product will be developed into proven medicines.”

Here’s where we are with respect to CBD in the second half of 2019.

Excerpted from Law360. To read the full article, click here. (Subscription required)

Related Practices

Related Industries

Email Disclaimer